Wuxi to use Insilico's AI platform to speed drug discovery

WuXi AppTec Co. Ltd. (Shanghai:603259) led a venture round for Insilico Medicine Inc. (Baltimore, Md.) and partnered with the artificial intelligence company to discover and develop new molecules.

Insilico CEO Alex Zhavoronkov told BioCentury it raised $5-$10 million in the round but declined to provide a specific number. ...